Skip to main content
OpenTrials
Completed

NCT Number: NCT06480916

Study of the Value of Maternal-fetal Transfers and Their Complexity of Their Implementation

It is an observational, descriptive, prospective, multicenter study of 8 maternity units in Lorraine and Champagne-Ardenne, aimed at comparing the percentage of "avoidable" maternal-fetal transfers (MFTs), defined as transfers in which the delivery finally meets the acceptance criteria of the sending maternity unit, according to the obstetrical indications for these MFTs.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Hopital Maillot, Briey, France

Loading trial locations.

About this study

Over the past year, an audit carried out on the Mercy maternity unit, covering 130 transfers to the Nancy regional maternity hospital, showed that patients transferred for threat of premature delivery (MAP) with a cervix > 15 mm do not give birth at the receiving maternity unit, but return home after 48 hours' hospitalization.

When maternal-fetal transfer (MFT) is requested, numerous calls are made to private ambulance services, and in the end, many emergency rapid response units (SMUR) are called out, requiring a major human, logistical and time investment for a questionable benefit to the patient. Tensions in terms of logistics (lack of ambulance, SMUR) and human resources (lack of personnel) can, conversely, compromise good care of the parturient.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pregnant woman cared for in a participating maternity unit
  • Over 18 years of age
  • Requested for maternal-fetal transfer (finally performed, or not)

Exclusion criteria

  • missing data on transfer outcome

Treatment and study plan

Maternal-fetal transfers

Procedure

Prospective and consecutive inclusion of all maternal-fetal transfers during the study period. The teams at the sending and receiving maternity units will complete study-related questionnaires to describe the conditions of the transfer and the outcome of the pregnancy. The study in no way alters the way parturients are cared for.

Primary outcomes

  1. The percentage of "avoidable" maternal-foetal transfer (MFT)

    Time frame: after delivery, up to 6 weeks after the maternal-foetal transfer

    The main evaluation criterion is "avoidable" maternal-foetal transfer (MFT), i.e. resulting in a delivery that met the acceptance criteria of the original maternity hospital

Secondary outcomes

  1. Obstetrical indication for maternal-foetal transfer (MFT)

    Time frame: Up to 48 hours after the maternal-foetal transfer

    as documented in the patient file

  2. Organizational arrangements for maternal-foetal transfer

    Time frame: Up to 6 months after inclusion of a maternity unit in the study

    Organizational arrangements for maternal-foetal transfer in the various centers, assessed by a specific questionnaire sent to maternity units.

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Régional Metz-Thionville

Other

Registry information

Acronym: TRANSFERT

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jun 28, 2024
Registry last updated
Jun 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.